1 Min Read
May 26 (Reuters) - Minerva Neurosciences Inc :
* Minerva Neurosciences announces positive results in Phase IIA trial of MIN-117 in major depressive disorder Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.